
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Document Content</title>
    <style>
        body { font-family: Arial, sans-serif; line-height: 1.6; max-width: 900px; margin: auto; padding: 20px; }
        table { border-collapse: collapse; width: 100%; margin-top: 20px; margin-bottom: 20px; }
        th, td { border: 1px solid #cccccc; text-align: left; padding: 8px; font-size: 12px; }
        tr:nth-child(even) { background-color: #f9f9f9; }
        th { background-color: #3366CC; color: white; font-weight: bold; }
        h2 { color: #4F81BD; border-bottom: 2px solid #4F81BD; padding-bottom: 5px;}
        p { margin-block-start: 0.5em; margin-block-end: 0.5em; }
    </style>
</head>
<body>
    <p style="font-size: small; color: grey;"><i>z_TPG VII_2018Q2 FS-PTF_031.pdf</i></p>
<p>TPG Partners VII, L.P. and Affiliated Partnerships <sup>COMBINED STATEMENTS OF INVESTMENTS (Dollars in Thousands, Except Share Data)</sup></p>
<p>June 30, 2018</p>

<table>
	<tr>
		<th>Portfolio Investments</th>
		<th>Fair Value Hierarchy</th>
		<th>Type of Investment</th>
		<th>Description</th>
		<th>Cost</th>
		<th>Fair Value</th>
	</tr>
	<tr>
		<td>North America</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Allogene Therapeutics</td>
		<td>Level III</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Pharmaceuticals, Biotechnology and Life Science</td>
		<td></td>
		<td>Equity</td>
		<td>Allogene Therapeutics, Inc. - Series A Preferred Shares - 2,852,071</td>
		<td>$ 50,000</td>
		<td>$ 50,000</td>
	</tr>
	<tr>
		<td>Amneal</td>
		<td>Level I</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Pharmaceuticals, Biotechnology and Life Science</td>
		<td></td>
		<td>Equity</td>
		<td>Amneal Pharmaceuticals, Inc. (NYSE: AMRX) - Class B-1 Common Shares - 12,328,767</td>
		<td>225,000</td>
		<td>202,300</td>
	</tr>
	<tr>
		<td>Beaver-Visitec International</td>
		<td>Level III</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Healthcare Equipment and Services</td>
		<td></td>
		<td>Equity</td>
		<td>Bedrock Holdings, Inc. - Common Shares - 381,475</td>
		<td>381,530</td>
		<td>473,600</td>
	</tr>
	<tr>
		<td>Cirque du Soleil</td>
		<td>Level III</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Media</td>
		<td></td>
		<td>Equity</td>
		<td>Cirque Du Soleil Holdings, LP - Common Units - 318,850,000</td>
		<td>318,925</td>
		<td>372,600</td>
	</tr>
	<tr>
		<td>Cushman &amp; Wakefield</td>
		<td>Level III</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Real Estate</td>
		<td></td>
		<td>Equity</td>
		<td>DTZ Jersey Holdings Limited - Ordinary Shares - 191,293,333.33</td>
		<td>229,600</td>
		<td>363,800</td>
	</tr>
	<tr>
		<td>Ellucian</td>
		<td>Level III</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Software and Services</td>
		<td></td>
		<td>Equity</td>
		<td></td>
		<td>554,600</td>
		<td>562,800</td>
	</tr>
	<tr>
		<td>EnLink Midstream</td>
		<td>Level III</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Energy</td>
		<td></td>
		<td>Equity</td>
		<td>EnLink Midstream Partners, LP - Series B Preferred Units - 31,096,679.61
Confidential</td>
		<td>456,685</td>
		<td>552,680</td>
	</tr>
	<tr>
		<td>Exactech</td>
		<td>Level III</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Healthcare Equipment and Services</td>
		<td></td>
		<td>Equity</td>
		<td>Osteon Holdings, Inc. - Class A Common Shares - 465,000</td>
		<td>465,000</td>
		<td>465,000</td>
	</tr>
	<tr>
		<td>Life Time Fitness</td>
		<td>Level III</td>
		<td></td>
		<td>-highly</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Consumer Services</td>
		<td></td>
		<td>Equity</td>
		<td>LTF Holdings, Inc. - Common Shares - 44,810,433.10</td>
		<td>448,200</td>
		<td>876,400</td>
	</tr>
	<tr>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>LLamasoft</td>
		<td>Level III</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Software and Services</td>
		<td></td>
		<td>Equity
TPG</td>
		<td>Laurel Parent Holdings, Inc. - Common Shares - 1,948,355</td>
		<td>194,835</td>
		<td>212,100</td>
	</tr>
	<tr>
		<td>McAfee</td>
		<td>Level III</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Software and Services</td>
		<td></td>
		<td>Equity</td>
		<td>Foundation Technology Worldwide, LLC - Common Units - 27,073,005</td>
		<td>206,892</td>
		<td>812,200</td>
	</tr>
	<tr>
		<td>Mediware</td>
		<td>Level III</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Healthcare Equipment and Services</td>
		<td></td>
		<td>Equity</td>
		<td>TPG VII Meso Acquisition, Inc. - Ordinary Shares - 536,467.50</td>
		<td>536,467</td>
		<td>730,600</td>
	</tr>
	<tr>
		<td>RCN / Grande</td>
		<td>Level III</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Media</td>
		<td></td>
		<td>Equity</td>
		<td>Radiate Holdings, LP - Class A Units - 423,298,460 Radiate Holdings, LP - Class C Units - 312,500</td>
		<td>648,371</td>
		<td>1,077,700</td>
	</tr>
	<tr>
		<td>Rodan &amp; Fields</td>
		<td>Level III</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Household and Personal Products</td>
		<td></td>
		<td>Equity</td>
		<td>Rodan &amp; Fields, LLC - 25% Class D Membership Interest</td>
		<td>480,740</td>
		<td>473,184</td>
	</tr>
	<tr>
		<td>Transplace Holdings</td>
		<td>Level III</td>
		<td rowspan="2">Equity</td>
		<td rowspan="2">Transplace Holdings, Inc. - Common Shares - 905.67</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Transportation</td>
		<td></td>
		<td>401,898</td>
		<td>401,898</td>
	</tr>
	<tr>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td>Continued</td>
	</tr>
</table>
<p>PAR PE Information and Records parpedocumentation@ardian.com https://services.sungarddx.com/Attachment/InvestorAttachment?attachmentId=15408623 08/14/2018 08:14:44</p>
<p style="font-size: small; color: grey;"><i>Valuation may include amounts held in deal structure Securities may be held directly or indirectly</i></p>
<p style="font-size: small; color: grey;"><i>31</i></p>

</body>
</html>
